Ranbaxy Laboratories Ltd has commenced Yemen operations

Homegrown pharma major Ranbaxy Laboratories Ltd has commenced Yemen operations in collaboration with local Pharma Ltd. With this it has strengthened its presence in the Middle-East. Ranbaxy has now become the first Indian pharma company to have a strong presence in the Middle-East with operations in 11 countries.

The company has a strong productline with over 160 approvals so far in Yemen. It has commenced operation by introducing products to more than 350 doctors in the country. Ranbaxy would focus more on therapeutic areas such as anti-infectives, gastro-intestine, cholesterol lowering and anti-allergic in the country. It has also become the first company to be registered in Saudi Arabia and to receive the centralised GCC registration.